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This work addresses the removal of glucocorticosteroids (hydrocortisone, HYDRO;
and dexamethasone, DEXA) and anesthetics (procaine, PROCA; and lidocaine, LIDO),
from water with commercially available reverse osmosis/nanofiltration (RO/NF) mem-
branes. The RO/NF experiments were of long-run type (24 h) in order to accomplish
steady-state and to obtain accurate rejection of the selected compounds. The removal of
the examined compounds with the RO (XLE, SWC1, LFC–1) and the tight NF (NF90)
membranes was higher than 98 %. Relating the solute rejections to membranes' proper-
ties has shown that the dominant rejection mechanism of the examined pharmaceuticals
by all the membranes was the size exclusion effect.
Rejection factors for hydrophilic HYDRO and DEXA compounds confirm that they
do not adsorb onto the active layer of the selected membranes. LIDO and PROCA,
slightly hydrophobic compounds, had lower rejections after 24 h treatment compared to
initial values, and probable they were adsorbed onto polymeric matrix of active layers.
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Introduction
Over the past decade, pharmaceuticals are con-
sidered as an emerging environmental problem due
to their continuous release and persistence in the
aquatic ecosystem even at low concentrations.1,2 In
recent years, the use of pharmaceuticals in veteri-
nary and human medicine is widespread (annual
consumption of 100,000 – 200,000 t globally) and
consequently, the possibility of water contamina-
tion with such compounds has increased.3 They
have been detected worldwide in environmental
matrices (surface, ground and even drinking wa-
ter),4,5 indicating their ineffective removal from wa-
ter and wastewater using conventional treatment
methods.1,6,7
Dexamethasone (DEXA) and hydrocortisone
(HYDRO) belong to the glucocorticoid class of
synthetic steroid hormones. Dexamethasone is used
to treat many inflammatory and autoimmune condi-
tions, such as rheumatoid arthritis, while hydrocor-
tisone is released in response to stress and a low
level of blood glucocorticoids. Hydrocortisone’s
primary functions are to increase blood sugar
through gluconeogenesis, suppress the immune sys-
tem and aid in fat, protein and carbohydrate metab-
olism.
Lidocaine (LIDO), an amide synthesized from
cocaine, is one of the most extensively used local
anesthetics and peripheral analgesics, effective in
pain reduction. The second anesthetic investigated
in this work was procaine (PROCA), a local anes-
thetic drug of the amino ester group. It is used pri-
marily to reduce the pain of intramuscular injection
of penicillin, and also used in dentistry.
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Membrane treatment technologies of reverse
osmosis (RO) and nanofiltration (NF) are recog-
nized as successful removal technologies for vari-
ous pharmaceuticals from water.8–11 The usage of
these treatments is growing every year compared to
other water treatment technologies and are be-
coming increasingly common in water treatment
plants,10,12–17 but according to the authors' knowl-
edge, no articles on the removal of HYDRO,
DEXA, LIDO and PROCA were published, except
our previous paper for removal of DEXA.18 In this
paper the removal of DEXA from Milli-Q water
with RO/NF membranes (XLE, LFC–1, NF90,
NF270, NF and HL) was higher than 99 %. There-
fore, the aim of this work was to investigate the
removal of glucocorticosteroids (HYDRO and
DEXA) and anesthetics (LIDO and PROCA) from
water with RO/NF membranes in a long-term ope-
ration (24 h) to find accurate rejection.
Materials and methods
Chemicals
The purities of the drugs were  97 %, as de-
termined by the supplier (Veterina, Croatia). The
chemical structures of the pharmaceutical sub-
stances and their physico-chemical properties are
presented in Table 1. These compounds represent a
hydrophilic group (with little approach to hydro-
phobic for LIDO and PROCA) of micropollutants
and are different in size and solubility, which could
influence membrane rejection.
Solutions of the individual standards, and their
mixture were prepared in Milli-Q water. The con-
centration of each drug in the solutions was around
15 mg L–1.
Molecular size (length and width) of the com-
pounds were determined with software package
“HyperChem 8.0”. The molecular mechanics was
applied to optimize the conformation of each com-
pound. The conformations with minimal energy
were found using the Polak-Ribiere algorithm, with
a convergence limit of 0.4184 kJ mol–1 or a maxi-
mum number of calculation cycles set at 390.
Membranes
The commercially available RO and NF mem-
branes examined in this work included the XLE
(Dow/FilmTec, Midland MI), LFC–1, CPA3 and
SWC1 (Hydranautics, Oceanside, CA) polyamide
RO membranes, and NF90 and NF270 (Dow/
FilmTec) polyamide NF membranes. All mem-
branes were stored in a dark, cold place (refri-
gerator) and their characteristics are presented in
Table 2.
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T a b l e 1 – Physico-chemical properties of the selected micropollutants
Formula
HYDRO DEXA PROCA LIDO
C21H30O5 C22H29F1O5 C13H20N2O2 C14H22N2O1
CAS number 000050-23-7 000050-02-2 000059-46-1 000137-58-6
MW (g mol–1) 362.47 392.47 236.32 234.34
log KO/W
a 1.61 1.83 2.14 2.44
Water solubility b (mg L–1) 320 89 9450 4100
Dipole moment (µ) (D) c 4.14 6.30 4.00 3.54
pKa
d 13.86 13.48 8.05 8.01
dc
e 0.859 0.889 0.712 0.709
Molecular structure
Width f (nm) 0.505 0.613 0.559 0.483
Length f (nm) 1.167 1.015 0.969 0.908
a Obtained from EPI SUITETM v4.10
b HYDRO and DEXA at 25 °C and PROCA and LIDO at 30 °C
c dipole moment calculated by Gaussian19
d Obtained from Syracuse Corporation (SRC) PhysProp database (http://www.syrres.com/esc/physdemo.htm) and http://www.drugbank.ca
e dc effective diameter of organic compound in water (dc=0.065 · (MW)
0.438)
f calculated with HyperChem 8.0
The membranes were tested in a laboratory
set-up shown and described previously in details in
Dolar et al.18 at the laboratory temperature of 25
°C, working pressure of 10 bar and cross-flow
mode (flow rate 500 mL min–1). The preserved
membranes were first washed with demineralized
water without pressure and then pressurized at 15
bar for 3 h. The nominal characteristics of the mem-
branes were checked with solutions of sodium and
calcium chloride (Kemika, Croatia). The concen-
tration of the inorganic solutes in the feed was 300
mg L-1.







with cp and cf as permeate and feed concentrations,
respectively was determined in each experiment.
NF/RO experiments with the pharmaceutical solu-
tions were of the long-run type, each lasting for 24
hours. Samples of the individual compounds were
taken at the beginning of the experiment (0 h), and
after 2, 4, 6, 8, 12 and 24 h, and for the mixture at
the beginning (0 h) and the end (24 h) of the experi-
ment.
The membranes were cleaned after each exper-
iment. Cleaning was performed at temperature
around 35 °C with commercially available RoClean
L211 (1.5 % alkaline agent) supplied by Avista
Technologies Ltd (UK).
Analytical determination
The concentrations of inorganic salts NaCl and
CaCl2 were determined by the conductometer (In-
struments Lab 960 SCHOTT, Germany).
The glucocorticosteroids and anesthetics were
analyzed using a Varian ProStar 500 (Walnut
Creek, CA, USA) HPLC system consisting of a Pro-
Star 410 autosampler, ProStar 230 tertiary pump
system, ProStar 330 diode array detector, and
thermostatted column compartment. The column
temperature was set to 20 °C and injection volume
was 30 µL. C18 Synergy Fusion 150 mm × 4.6 mm,
particle size 4 µm column (Phenomenex) was used
to separate DEXA and HYDRO, and Luna CN 100
mm × 4.6 mm, particle size 3 µm column
(Phenomenex) was used to separate PROCA and
LIDO. The same mobile phase used in the chro-
matographic separation consisted of a binary mix-
ture of solvents A (0.01 % formic acid in water) and
B (0.01 % formic acid in acetonitrile). Same mobile
phase gradient program was used for both columns:
elution started with 2.5 min linear gradient from 0
% A to 8 % B, followed by 3.5 min linear gradient
to 10 % B, 5 min linear gradient to 30 % B, 4 min
linear gradient to 60 % B and finally 3 min linear
gradient to 95 % B which was maintained for 10
min and then 0.1 min linear gradient back to 100 %
of A. The flow rate was 0.5 mL min–1. The separa-
tion was monitored at absorbance wavelength of
245 nm for DEXA and HYDRO, for PROCA at 300
nm and for LIDO at 210 nm. The limits of detec-
tions (LODs) were 0.012 mg L–1 for DEXA and
HYDRO and 0.050 mg L–1 for PROCA and LIDO.
Results and discussion
The nominal characteristics of membranes
were checked with two typical inorganic salts, so-
dium and calcium chloride, while their initial rejec-
tion factors are shown in Table 3. The rejection of
ionic inorganic solutes by a membrane is regularly
measured in order to compare basic properties and
the rejection mechanism of the examined mem-
branes. The proximity of the RNaCl and RCaCl2 values
in case of the RO membranes (XLE, SWC1 and
LFC–1) indicates the governing size exclusion
mechanism of the solute rejection.18,27,28 Initial
value of RNaCl obtained on CPA3 RO membrane
was only 76.0 %, and this was assumed an experi-
mental error since the manufacturer guarantees 99.7
%. Comparing the flux values measured in this
work (2.8 L m–2 h–1 bar–1) and guaranteed by the
manufacturer (3.0 L m–2 h–1 bar–1), aforementioned
D. DOLAR et al., Removal of Glucocorticosteroids and Anesthetics from Water …, Chem. Biochem. Eng. Q. 27 (1) 1–6 (2013) 3
T a b l e 2 – Membrane characteristics
Membrane LFC–1 XLE NF90 NF270 SWC1 CPA-3
MWCO18 100 100 100–200 150–300 100 100
RNaCl (%)
a 91.06 92.44 83.40 20.53 98.64 76.02
RCaCl2 (%)
a 96.07 98.74 96.38 43.33 83.21 96.29
Jw (L m
–2 h–1) b 24.30±0.64 83.79±4.22 84.76±8.15 145.11±10.42 7.13±0.92 27.79±1.26
Contact angle
(°)20–26
16.4–23.8 46.4–66.3 44.7–63.2 29–55 41.7–55.9 73.0±10.0
a experimental from this study
b pure water flux (experimental data from this study (N=5))
experimental error was confirmed. Relatively larger
differences between rejection factor of monovalent
and divalent salts in case of nanofiltration NF270
membrane, indicate strong repelling action of NF
membranes on divalent ions, confirming the pres-
ence of a noticeable electrical charge on these
membranes. This result shows that the charge ex-
clusion effect prevails for ionic solutes rejection by
NF membranes.18,27,28
Except at the beginning, the rejection factors of
inorganic salts were also measured two times, after
processing of the individual DEXA solution and af-
ter passing the mixture solution, followed by clean-
ing, in order to examine the changes on membrane
characteristics due to adsorption of organic com-
pounds. The negligibly increase in rejection of inor-
ganic salts for almost all the membranes (Table 3)
confirms that the membranes had not been perma-
nently fouled, and that their structure had not been
changed. The rejection factors of CaCl2 were the
same at the beginning and end.
T a b l e 3 – Rejection factors, R of inorganic salts NaCl and
CaCl2 during membrane treatment
R / %
XLE SWC1 LFC–1 NF270 CPA3 NF90
NaCl
1 92.4 98.6 91.1 20.5 76.0 83.4
2 97.6 98.8 96.1 22.5 94.4 94.5
3 97.4 98.3 97.5 28.6 94.0 94.8
CaCl2
1 96.1 98.7 96.4 43.3 83.2 96.3
3 96.8 98.1 96.3 – 88.3 96.4
1 – start (initial)
2 – after processing the DEXA followed by cleaning
3 – after processing the mixture followed by cleaning
RO/NF experiments with pharmaceutically ac-
tive compounds were performed in a long-term op-
eration (24 h) in order to examine the physico-
chemical interactions in membrane system between
the solute and the membrane and to obtain accurate
rejection of the selected compound. It should be
also pointed that the objective of this work was to
examine the removal of emerging contaminants, so
holdup tank and flasks for collecting permeate were
covered with aluminum foil to prevent photodegra-
dation.29
Due to accomplishing steady-state, samples of
permeate were taken at 0, 2, 4, 6, 8, 12 and 24 h of
the treatment, and Kimura et al.30 showed that
steady-state was accomplished after 6 hours.
Rejection factors of the selected compounds at
the sampling times are presented in Table 4.
T a b l e 4 – Rejection factors, R of the selected compounds
during 24 h treatment
R / %
LIDO PROCA HYDRO DEXA
XLE
0 h 98.4 99.6 99.3 99.3
2 h 97.3 96.0 99.3 99.5
4 h 97.7 96.4 99.3 99.5
6 h 97.5 95.5 99.3 99.4
8 h 97.2 95.0 99.3 99.4
12 h 98.1 95.7 99.3 99.5
24 h 98.3 96.0 98.8 99.6
SWC1
0 h >99.9 >99.9 99.9 99.9
2 h 99.3 99.3 99.6 99.6
4 h 98.6 98.4 99.6 99.6
6 h 98.8 98.0 99.6 99.6
8 h 98.5 97.5 99.5 99.6
12 h 98.3 97.7 99.5 99.6
24 h 98.6 97.6 99.6 99.6
LFC–1
0 h >99.9 >99.9 99.6 99.8
2 h >99.9 99.4 99.5 99.7
4 h >99.9 99.4 99.6 99.8
6 h >99.9 99.3 99.5 99.7
8 h >99.9 99.4 99.5 99.8
12 h >99.9 99.4 99.4 99.7
24 h >99.9 99.4 99.7 99.8
NF270
0 h 60.8 69.1 94.8 99.1
2 h 56.8 50.7 94.9 99.0
4 h 55.3 50.0 95.2 99.0
6 h 56.6 48.7 95.1 99.1
8 h 59.0 44.9 95.2 99.0
12 h 63.0 47.3 95.6 99.2
24 h 61.6 43.2 95.7 99.1
CPA3
0 h 98.8 99.6 95.8 98.2
2 h 86.8 93.2 92.2 96.3
4 h 81.8 90.4 93.9 96.6
6 h 82.9 89.0 93.6 96.8
8 h 84.0 86.0 94.0 96.8
12 h 82.5 88.3 94.6 96.7
24 h 77.2 91.6 94.5 97.1
NF90
0 h 99.3 99.6 99.4 99.6
2 h 99.4 98.5 99.3 99.6
4 h 99.1 98.5 99.3 99.6
6 h 99.1 98.6 99.4 99.6
8 h 99.1 98.4 99.3 99.6
12 h 99.2 98.7 99.4 99.6
24 h 99.2 98.8 99.4 99.7
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At the beginning of the experiment (0 h), the
highest rejections were for RO membranes, i.e. all
investigated compounds were removed more than
98 %. This can be explained with size exclusion
mechanism, because molecular weight (MW) of the
compounds (Table 1) are larger than molecular
weight cut off (MWCO) of the RO membranes20
(Table 2). In addition, molecular lengths of the
compounds are between 0.908 nm and 1.167 nm,
compared to pore sizes of reverse osmosis mem-
branes, less than 1 nm.18,28 The same behavior was
displayed by the tight NF90 nanofiltration mem-
brane, which has similar porous structure to RO
membrane. The second tight NF270 membrane had
rejection 60.8 % and 69.1 % for smaller compounds
(LIDO and PROCA) and due to the size exclusion
mechanism, rejection increased with MW, i.e. mo-
lecular length. Košutiæ et al.28 classified NF90 and
NF270 into tight NF membranes and showed that
the pore size distribution of NF270 membrane is bi-
modal with the main peak at 0.90 nm and an ad-
ditional peak at 1.56 nm, making the distribution
similar to those of the loose NF membranes. The
presence of larger pores in active layer of NF270
membranes makes it permeable for smaller com-
pounds of LIDO and PROCA.
Rejection factors obtained for HYDRO, pre-
sented in Table 4, were constant for all used mem-
branes, except for NF270 and CPA3, which had
negligibly increase. The same results can be ob-
served for DEXA (Table 4). All rejection factors
were relatively constant. HYDRO and DEXA are
hydrophilic compounds due to log KO/W 1.61 and
1.83, respectively. The rejection factors confirm
that these hydrophilic compounds do not adsorb on
the membrane polymeric matrix (membrane active
layer or “skin”)31 but were effectively rejected by
RO/NF membranes via steric hindrance or the size
exclusion mechanism30,31 due to larger length of the
compounds than pores of the selected membranes.
For PROCA and LIDO, the rejection factors
decreased for some membranes (SWC1, NF270 and
CPA3). These compounds are smaller (MW around
230 g mol–1) with log KOW > 2, representing slightly
more hydrophobic compounds. This is important
for removal because Nghiem et al.32 stated that hy-
drophobic trace organics can adsorb onto the mem-
brane surface and subsequently may diffuse
through RO and, in particular, NF membranes. For
both compounds, the rejections were constant dur-
ing long-term operation for XLE, LFC-1 and NF90
membranes. Therefore, it could be concluded that
they did not adsorb or diffuse through membrane
polymeric matrix. For other membranes (SWC1,
NF270 and CPA3) rejections were not constant,
therefore, adsorption has to be taken into account
together with size exclusion, showing that removal
of some hydrophobic compounds can actually be
lower than that predicted based solely on a steric
hindrance transport model. Decrease in rejection
confirmed that smaller and slightly hydrophobic
compounds can adsorb onto active membrane layer
and consequently can diffuse through it.
In the mixture solution, (Table 5), RO/NF
membranes almost completely removed all investi-
gated compounds, and, in general, it can be con-
cluded that the rejection is even better than from in-
dividual solutions. In the case of RO and tight
NF90 membranes, no significant difference be-
tween rejection in individual and mixture solutions
is observed because these membranes provided
high removal ( 97 %) which is consistent with
Dolar et al.18,27 In addition, rejection of LIDO in the
mixture solution with CPA3 membrane was higher
than in an individual solution. This proves the posi-
tive synergy (an effect arising between two or more
compounds that produces an effect greater than that
of their individual effects) concerning the rejection
effectiveness.9,18,27
T a b l e 5 – Rejection factors, R of the selected compounds
in mixture solution at the beginning (0 h) and
the end of treatment (24 h)
R / %
LIDO PROCA HYDRO DEXA
XLE 0 h 98.9 99.4 99.0 99.5
24 h 99.0 97.8 99.1 99.6
SWC1 0 h 99.9 99.9 99.9 99.9
24 h 98.5 97.4 99.6 99.8
LFC–1 0 h 99.9 99.9 99.7 99.9
24 h 99.8 99.4 99.7 99.9
NF270 0 h 87.8 57.8 93.8 96.7
24 h 91.8 70.1 96.7 97.6
CPA3 0 h 99.2 99.7 98.0 98.7
24 h 93.2 90.8 95.2 97.2
NF90 0 h 99.4 99.6 99.4 99.8
24 h 99.5 99.2 99.7 99.7
Rejection of LIDO and PROCA obtained on
nanofiltration NF270 membrane were higher in
mixture which could be also attributed to the syn-
ergy effect, i.e. larger molecules (HYDRO and
DEXA) increased separation of smaller molecules
(LIDO and PROCA).
Conclusions
The efficiency of several RO/NF membranes in
removing some frequently used glucocorticostero-
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ids and anesthetics drugs from Milli-Q water was
determined. The removal of the examined pharma-
ceuticals by the RO (XLE, SWC1, LFC–1) and the
tight NF (NF90) membranes is higher than 98 %.
The second tight nanofiltration NF270 membrane
however did not retain the smaller LIDO and
PROCA molecules satisfactorily (60.8 % and 69.1
%, respectively). Relating the solute rejections to
membranes' properties has shown that the dominant
rejection mechanism of the examined unionizable
drugs by all the membranes was the size exclusion
effect.
In the mixture solution additional synergistic
effect was observed and had influence on rejection,
i.e. higher rejection of smaller LIDO and PROCA
molecules were obtained.
Rejection factors for hydrophilic HYDRO and
DEXA compounds were very similar and confirm
that they do not adsorb onto the active layer
(“skin”) of polymeric polyamide membranes. Com-
pounds with slightly higher log KO/W values (LIDO
and PROCA), i.e. with weak hydrophobic charac-
teristics, had lower rejections after 24 h treatment
compared to initial values and were probably ad-
sorbed onto the polymeric matrix and even diffused
through it.
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